
June 24 (Reuters) - The U.S. military has resumed requiring flu vaccines for some service members in an exception to Defense Secretary Pete Hegseth...



(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:


(Alliance News) - GSK PLC on Wednesday said it has launched the tender offer for its previously announced acquisition of US-based cancer drug develope...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Wednesday and not separately reported by Alliance New...

GSK PLC - London-based pharmaceuticals firm - Non-Executive Chair Jonathan Symonds buys 1,550 shares at GBP19.35 for total GBP29,992.50 last Friday. D...

Cambridge Cognition Holdings PLC - brain health software provider based in Cambridge, England - Plans to raise a minimum of GBP2.5 million through a G...

Thalia Therapeutics PLC - biotechnology company developing innovative RNA therapeutics - Pretax loss is flat at GBP1.2 million in 2025 when compared t...

(Alliance News) - Integrated Diagnostics Holdings PLC on Tuesday confirmed it has received a USD290.7 million takeover bid from investor Hena Holdings...

(Alliance News) - Integrated Diagnostics Holdings PLC investor Hena Holdings Ltd on Tuesday confirmed a USD 290.7 million takeover bid for the company...

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and Friday and not separately reported by Allian...

(Alliance News) - Ondine Biomedical Inc on Monday announced an update on its Lantern phase 3 pivotal study evaluating the company's non-antibiotic nas...

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

(Alliance News) - CelLBxHealth PLC shares fell on Monday as it reported a wider loss and lower revenue for 2025 in a "year of significant transition".

(Alliance News) - Avacta Group PLC on Monday said it continued its "strong progress" in the first half of 2026.

* FDA advisers back mFlusiva's benefits for adults 50 and up

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Advanced Medical Solutions Group PLC - Cheshire, England-based surgical dressings company - Announces the extension of the put-up-or-shut-up deadline ...

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

(Alliance News) - GSK PLC and Spero Therapeutics Inc on Wednesday said that the US Food & Drug Administration has approved Utebzi, an oral antibiotic ...